Translational Drug Development (TD2)
Kasey Clark is a skilled professional with a strong background in research and data analysis. Currently serving as a Data Specialist and formerly as a Research Associate at Translational Drug Development (TD2) since December 2019, Kasey possesses extensive experience in biotechnologies, having worked as a Researcher at Human Rejuvenation Biotechnologies LLC from December 2017 to July 2019. Kasey began the career as a Veterinary Technician at mesa spay and neuter, where employment lasted from July 2013 to April 2017. Kasey holds a Bachelor of Applied Science degree in Applied Biology from Arizona State University, completed between 2014 and 2017.
This person is not in the org chart
Translational Drug Development (TD2)
Translational Drug Development (TD2) is an oncology-focused Contract Research Organization (CRO) that supports improved and accelerated development of medicines for life-threatening diseases. We help companies move their drugs through the critical stages of preclinical, regulatory and clinical trial processes. Our scientific depth, proactive problem solving, and strategic direction and advice increase the likelihood of positive outcomes that bring hope and a better quality of life to cancer patients and their families. TD2 was born from the Translational Genomics Research Institute (TGen) as a nonprofit in 2003. TGen’s deep scientific expertise and approach to interrogating the “omic” drivers of disease is at the heart of TD2’s heritage and has become the foundation upon which TD2 creates unique clinical strategies for its clients.